Clinical Trial Update: Efficacy and Safety of Olmesartan Medoxomil in Stage 1 and 2 Essential Hypertension [Phase 4]

View source ↗

Summary

Phase 4 study update assessing the efficacy and safety of olmesartan medoxomil for stage 1 and stage 2 essential hypertension. Results were posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• OLMESARTAN MEDOXOMIL (olmesartan medoxomil)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Essential Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2009-04-30